Sunnie S Kim (Sunnie Kim)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Randomized Controlled Trial

Histone Deacetylase

Sentinel Lymph Node

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford, Kimberley R Jordan, Todd M Pitts, Hannah R Robinson, S Lindsey Davis, Sunnie S Kim, Alexis D Leal, Matthew R Lee, Meredith R N Waring, Anne C Martin, Adrian T A Dominguez, Stacey M Bagby, Sarah J Hartman, S Gail Eckhardt, Wells A Messersmith, Christopher H Lieu
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Elliott J Yee, Danielle Gilbert, Jeffrey Kaplan, Sachin Wani, Sunnie S Kim, Martin D McCarter, Camille L Stewart
Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center. Cancers 16 (7) (2024)
Elliott J Yee, Danielle Gilbert, Jeffrey Kaplan, Sachin Wani, Sunnie S Kim, Martin D McCarter, Camille L Stewart
Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center. Cancers 16 (7) (2024)
Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford, Kimberley R Jordan, Todd M Pitts, Hannah R Robinson, S Lindsey Davis, Sunnie S Kim, Alexis D Leal, Matthew R Lee, Meredith R N Waring, Anne C Martin, Adrian T A Dominguez, Stacey M Bagby, Sarah J Hartman, S Gail Eckhardt, Wells A Messersmith, Christopher H Lieu
A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite stable colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elliott J Yee, Danielle Gilbert, Jeffrey Kaplan, Sachin Wani, Sunnie S Kim, Martin D McCarter, Camille L Stewart
Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center. Cancers 16 (7) (2024)
Jacob B Leary, Junxiao Hu, Alexis Leal, S Lindsey Davis, Sunnie S Kim, Robert W Lentz, Tyler J Friedrich, Whitney Herter, Wells A Messersmith, Christopher H Lieu
Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer. JCO oncology practice (2024)
Abhishek Pandey, Christopher H Lieu, Sunnie S Kim
The Local Microbiome in Esophageal Cancer and Treatment Response: A Review of Emerging Data and Future Directions. Cancers 15 (14) (2023)
Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, S Lindsey Davis, Christopher H Lieu, Sunnie S Kim, Antonio Jimeno, D Ross Camidge, Jud Williams, Amy M Heim, Anne Martin, John A DeMattei, Nisha Holay, Todd A Triplett, S Gail Eckhardt, Kevin Litwiler, James Winkler, Anthony D Piscopio, Jennifer R Diamond
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers 16 (1) (2023)
Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, S Lindsey Davis, Christopher H Lieu, Sunnie S Kim, Antonio Jimeno, D Ross Camidge, Jud Williams, Amy M Heim, Anne Martin, John A DeMattei, Nisha Holay, Todd A Triplett, S Gail Eckhardt, Kevin Litwiler, James Winkler, Anthony D Piscopio, Jennifer R Diamond
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers 16 (1) (2023)
Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, S Lindsey Davis, Christopher H Lieu, Sunnie S Kim, Antonio Jimeno, D Ross Camidge, Jud Williams, Amy M Heim, Anne Martin, John A DeMattei, Nisha Holay, Todd A Triplett, S Gail Eckhardt, Kevin Litwiler, James Winkler, Anthony D Piscopio, Jennifer R Diamond
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers 16 (1) (2023)